KeyBanc has revised its price target for Inspire Medical Systems, Inc. (INSP, Financial), reducing it from $234 to $216. Despite the adjustment, the firm maintains an Overweight rating on the stock. The decision to lower the price target arises from broader economic considerations, including concerns about potential tariff impacts and the increasing likelihood of a recession. While the outlook for the MedTech sector remains largely positive as the first quarter earnings season approaches, KeyBanc is taking a cautious stance by adjusting several of its price targets in response to these macroeconomic issues.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for Inspire Medical Systems Inc (INSP, Financial) is $229.87 with a high estimate of $280.00 and a low estimate of $175.00. The average target implies an upside of 53.03% from the current price of $150.21. More detailed estimate data can be found on the Inspire Medical Systems Inc (INSP) Forecast page.
Based on the consensus recommendation from 19 brokerage firms, Inspire Medical Systems Inc's (INSP, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Inspire Medical Systems Inc (INSP, Financial) in one year is $432.50, suggesting a upside of 187.93% from the current price of $150.21. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Inspire Medical Systems Inc (INSP) Summary page.
